$5 million grant to test Alzheimer’s treatment

Israel’s ImmunoBrain Checkpoint (see here previously) has been awarded a grant of $5 million over 3 years to support human clinical trials of IBC-Ab002, for the treatment of Alzheimer’s disease. Development was based on Weizmann Institute immune system studies.


This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.